Description of the medicine: Moxifloxacin (Moxifloxacin)
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7 - [(4aS, 7aS) -octahydro-6H-pyrrolo [3,4-b] pyridin-6-yl] -4-oxo- 3-quinolinecarboxylic acid.
Synonym: Avelox, Avelox.
The structure is close to ciprofloxacin.
It is active against most gram-negative and a number of gram-positive (staphylococcus, streptococcus) bacteria, anaerobes, acid-fast microorganisms, mycoplasmas, chlamydia and legionella. Effective in infections resistant to β-lactam antibiotics, macrolides and other chemotherapeutic drugs.
Applied with infections of the respiratory system, skin and soft tissues, acute sinusitis.
It is recommended for use in out-of-hospital settings.
Assign inside by 0.4 g 1 time per day. The course of treatment is from 5 days with chronic bronchitis to 10 days with community-acquired pneumonia.
The drug is well tolerated. Dyspepsia, a violation of the liver can be noted.
Contraindicated in pregnancy, breast-feeding, in childhood and adolescence.
Form release: tablets of 0.4 g (N. 5, 7, 10).
Storage: List B.